Nan Wang

16.5k total citations · 5 hit papers
91 papers, 12.4k citations indexed

About

Nan Wang is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Nan Wang has authored 91 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 53 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Nan Wang's work include Cholesterol and Lipid Metabolism (51 papers), Peroxisome Proliferator-Activated Receptors (29 papers) and Drug Transport and Resistance Mechanisms (29 papers). Nan Wang is often cited by papers focused on Cholesterol and Lipid Metabolism (51 papers), Peroxisome Proliferator-Activated Receptors (29 papers) and Drug Transport and Resistance Mechanisms (29 papers). Nan Wang collaborates with scholars based in United States, China and Netherlands. Nan Wang's co-authors include Alan R. Tall, Laurent Yvan‐Charvet, Philippe Costet, David L. Silver, Carrie L. Welch, Naoki Terasaka, Fumihiko Matsuura, Tamara A. Pagler, Yi Luo and Debin Lan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nan Wang

87 papers receiving 12.2k citations

Hit Papers

ATP-binding cassette transporters G1 and G4 mediate cellu... 1997 2026 2006 2016 2004 2000 1997 2010 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
    2004 851 citations Nan Wang, Alan R. Tall et al. profile →
  2. Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
    2000 838 citations Nan Wang, Alan R. Tall et al. Journal of Biological Chemistry profile →
  3. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux
    1997 605 citations Yong Ji, Jian Bo et al. Journal of Biological Chemistry profile →
  4. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
    2010 562 citations Laurent Yvan‐Charvet, Tamara A. Pagler et al. Science profile →
  5. Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
    2009 537 citations Laurent Yvan‐Charvet, Nan Wang et al. Arteriosclerosis Thrombosis and Vascular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Wang United States 52 8.0k 5.6k 3.7k 2.4k 2.3k 91 12.4k
Miranda Van Eck Netherlands 54 4.0k 0.5× 3.2k 0.6× 1.6k 0.4× 1.9k 0.8× 1.5k 0.6× 182 8.4k
Laurent Yvan‐Charvet United States 41 3.9k 0.5× 3.1k 0.6× 1.4k 0.4× 3.0k 1.2× 1.6k 0.7× 75 9.5k
Bryan Laffitte United States 20 5.1k 0.6× 4.2k 0.8× 2.6k 0.7× 1.1k 0.4× 1.3k 0.5× 32 7.4k
Liqing Yu United States 47 5.2k 0.6× 3.9k 0.7× 3.4k 0.9× 669 0.3× 1.1k 0.5× 112 8.9k
Linda K. Curtiss United States 67 5.1k 0.6× 4.8k 0.8× 1.3k 0.4× 5.8k 2.4× 1.9k 0.8× 190 15.0k
Yves L. Marcel Canada 56 4.9k 0.6× 4.5k 0.8× 843 0.2× 1.1k 0.5× 2.1k 0.9× 155 10.8k
Noam Zelcer Netherlands 43 3.1k 0.4× 3.3k 0.6× 3.2k 0.9× 1.3k 0.5× 1.1k 0.5× 95 8.6k
Nicolas Duverger France 38 3.3k 0.4× 2.9k 0.5× 1.3k 0.4× 1.0k 0.4× 968 0.4× 67 6.2k
Shinji Yokoyama Japan 49 4.4k 0.6× 3.2k 0.6× 1.9k 0.5× 485 0.2× 980 0.4× 214 7.1k
Steven F. Bronk United States 65 2.3k 0.3× 5.6k 1.0× 2.2k 0.6× 1.2k 0.5× 2.0k 0.9× 101 12.1k

Countries citing papers authored by Nan Wang

Since Specialization
Citations

This map shows the geographic impact of Nan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wang more than expected).

Fields of papers citing papers by Nan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wang. The network helps show where Nan Wang may publish in the future.

Co-authorship network of co-authors of Nan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Wang. A scholar is included among the top collaborators of Nan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Wang. Nan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Changjun, et al.. (2024). An interesting electrocardiogram caused by lead reversal. BMC Cardiovascular Disorders. 24(1). 217–217.
2.
Yalçınkaya, Mustafa, Wenli Liu, Tong Xiao, et al.. (2024). Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis. Journal of Lipid Research. 65(4). 100534–100534. 13 indexed citations
3.
Fidler, Trevor P., Andrew Dunbar, Eunyoung Kim, et al.. (2024). Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis. Nature Cardiovascular Research. 3(1). 60–75. 19 indexed citations
4.
Liu, Wenli, Nan Wang, & Alan R. Tall. (2023). Blockade of IL-6 Signaling Alleviates Atherosclerosis in Tet2 Deficient Clonal Hematopoiesis. SHILAP Revista de lepidopterología. 4. 100175–100175. 1 indexed citations
5.
Dou, Huijuan, Ranran Wang, Tong Xiao, et al.. (2023). Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis. Blood. 143(17). 1758–1772. 5 indexed citations
6.
Liu, Wenli, Mustafa Yalçınkaya, Malgorzata Olszewska, et al.. (2023). Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nature Cardiovascular Research. 2(6). 572–586. 38 indexed citations
7.
Yalçınkaya, Mustafa, Wenli Liu, Malgorzata Olszewska, et al.. (2023). BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis. Circulation. 148(22). 1764–1777. 42 indexed citations
8.
Yang, Bin, Nan Wang, Yanting Hu, et al.. (2023). HPF Modulates the Differentiation of BMSCs into HLCs and Promotes the Recovery of Acute Liver Injury in Mice. International Journal of Molecular Sciences. 24(6). 5686–5686. 2 indexed citations
9.
Endo‐Umeda, Kaori, Eun Young Kim, David G. Thomas, et al.. (2022). Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 42(6). 719–731. 54 indexed citations
10.
Yalçınkaya, Mustafa, Panagiotis Fotakis, Wenli Liu, et al.. (2022). Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion. Cardiovascular Research. 119(4). 969–981. 54 indexed citations
11.
Tall, Alan R. & Nan Wang. (2022). New insights into cholesterol efflux via ABCA1. Nature Cardiovascular Research. 1(3). 198–199. 2 indexed citations
12.
Lee, Man K.S., Dragana Dragoljevic, Camilla Bertuzzo Veiga, et al.. (2020). Interplay between Clonal Hematopoiesis of Indeterminate Potential and Metabolism. Trends in Endocrinology and Metabolism. 31(7). 525–535. 24 indexed citations
13.
Murphy, Andrew, Nora Bijl, Laurent Yvan‐Charvet, et al.. (2013). Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nature Medicine. 19(5). 586–594. 146 indexed citations
14.
Yvan‐Charvet, Laurent, Tamara A. Pagler, Emmanuel L. Gautier, et al.. (2010). ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation. Science. 328(5986). 1689–1693. 562 indexed citations breakdown →
15.
Tansley, Gavin, Braydon L. Burgess, Su Yuan, et al.. (2007). The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of β-amyloid precursor protein. Journal of Lipid Research. 48(5). 1022–1034. 46 indexed citations
16.
Chen, Wengen, Nan Wang, & Alan R. Tall. (2005). A PEST Deletion Mutant of ABCA1 Shows Impaired Internalization and Defective Cholesterol Efflux from Late Endosomes. Journal of Biological Chemistry. 280(32). 29277–29281. 89 indexed citations
17.
Silver, David L., Nan Wang, & Silke Vogel. (2003). Identification of Small PDZK1-associated Protein, DD96/MAP17, as a Regulator of PDZK1 and Plasma High Density Lipoprotein Levels. Journal of Biological Chemistry. 278(31). 28528–28532. 53 indexed citations
18.
Wang, Nan, David L. Silver, Christoph Thiele, & Alan R. Tall. (2001). ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein. Journal of Biological Chemistry. 276(26). 23742–23747. 405 indexed citations
19.
Wang, Nan, Takeshi Arai, Yong Ji, Franz Rinninger, & Alan R. Tall. (1998). Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic Mice. Journal of Biological Chemistry. 273(49). 32920–32926. 237 indexed citations
20.
Bo, Jian, Margarita de la Llera-Moya, Yong Ji, et al.. (1998). Scavenger Receptor Class B Type I as a Mediator of Cellular Cholesterol Efflux to Lipoproteins and Phospholipid Acceptors. Journal of Biological Chemistry. 273(10). 5599–5606. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miranda Van Eck Breakdown of academic impact, for papers by Laurent Yvan‐Charvet Breakdown of academic impact, for papers by Bryan Laffitte Breakdown of academic impact, for papers by Liqing Yu Breakdown of academic impact, for papers by Linda K. Curtiss Breakdown of academic impact, for papers by Yves L. Marcel Breakdown of academic impact, for papers by Noam Zelcer Breakdown of academic impact, for papers by Nicolas Duverger Breakdown of academic impact, for papers by Shinji Yokoyama Breakdown of academic impact, for papers by Steven F. Bronk
Rankless by CCL
2026